Ginkgo Bioworks DNA Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$312.76M+42.8% | -$547.03M+38.7% | -$892.87M+57.6% | -$2.11B-16.5% | ||
| $58.99M-6.4% | $63.02M-10.6% | $70.51M+65.7% | $42.55M+46.3% | ||
| $81.55M-27.4% | $112.34M-51.1% | $229.88M-88.1% | $1.93B+20.2% | ||
| -$171.06M+46.5% | -$319.59M-8.2% | -$295.5M-17.2% | -$252.2M+0.6% | ||
| $7.67M-87.7% | $62.54M+53.3% | $40.8M-21.9% | $52.27M-7.5% | ||
| —— | -$62.24M+22.9% | -$80.69M— | —— | ||
| $17.78M+1,122% | -$1.74M+45.9% | -$3.22M-103% | $95.34M-93.8% | ||
| —— | -$383.84M-1.0% | -$380M— | —— | ||
| -$178.72M+53.2% | -$382.13M-13.6% | -$336.3M-10.5% | -$304.47M+1.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ginkgo Bioworks generate?
- Ginkgo Bioworks (DNA) generated -$166.2M in operating cash flow over the trailing twelve months.
- What is Ginkgo Bioworks's free cash flow?
- After $2.0M of capital expenditures, Ginkgo Bioworks's free cash flow was -$168.2M over the trailing twelve months, up 51.3% year over year.
- Where does Ginkgo Bioworks's cash flow data come from?
- Every line is extracted from Ginkgo Bioworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
